Co-Diagnostics Inc (CODX) Stock Analysis

Co-Diagnostics Inc (CODX) is a publicly traded company in the HEALTHCARE sector. It trades at $6.22, carries a market capitalization of $22.85M. This page summarizes the public market data, fundamentals, and frequently asked questions for CODX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Co-Diagnostics Inc currently has a Bullish sentiment score of 0.35.

About Co-Diagnostics Inc

Co-Diagnostics, Inc. is an innovative molecular diagnostics company headquartered in Salt Lake City, Utah, recognized for its expertise in developing and manufacturing advanced reagents for diagnostic testing. Leveraging its proprietary technology for nucleic acid detection and analysis, the company is strategically positioned to meet the increasing global demand for accurate and efficient diagnostic solutions, particularly in the areas of infectious diseases and genetic disorders. Committed ...

GNG Research Analysis

GNG Research scores Co-Diagnostics Inc (CODX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CODX.

Frequently Asked Questions

Does CODX pay dividends?

Co-Diagnostics Inc (CODX) does not currently pay a regular dividend.

What is CODX's market cap?

Co-Diagnostics Inc (CODX) has a market capitalization of $22.85M with a current stock price of $6.22.